Regulation of neuroblastoma growth and differentiation by the POU family transcription factors Brn-3a and Brn-3b (review)

International Journal of Oncology

Volumn 10, Issue 6, 1997, Pages 1133-1139

  Latchman, David S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

neuroblastoma; transcription factors Brn 3a and Brn 3b

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN; PROOPIOMELANOCORTIN; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; NERVE FIBER GROWTH; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW;

EID: 0030938056     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.6.1133     Document Type: Review

References (33)

1. Verrijzer CP and van der Vliet PC: POU domain transcription factors. Biochim Biophys Acta 1173: 1-21, 1993.
2. Wegner M, Drolet DW and Rosenfeld MG: POU-domain proteins: structure and function of developmental regulators. Current Opin Developmental Biol 5: 488-498, 1993.
3. Gehring WJ: Homeoboxes in the study of development. Science 236: 1245-1252, 1987.
4. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LM and Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU domain gene Pit-1. Nature 347: 528-533, 1990.
5. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD and Wondisford FE: A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficency. Science 257: 1115-1118, 1992.
6. Desai C, Garriga G, McIntire SL and Horvitz HR: A genetic pathway for the development of Caenorhabditis elegans HSN motor neurons. Nature 336: 638-646, 1988.
7. Finney M, Ruvkin G and Horvitz HR: The C. elegans cell lineage and differentiation gene unc86 encodes a protein with a homeodomain and extended similarity to transcription factors Cell 55: 757-769, 1988.
8. de Kok JM, van der Maarel SM, Betner-Glinzicz M, Huber I, Monaco AP, Malcolm S, Pembery ME, Ropers HH and Gemers FPM: Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 267: 685-688, 1995.
9. Evans AE, D'Angio G, Knudson AG and Seeger RC: Advances in Neuroblastoma Research. 2, Alan R. Liss, New York, 1988.
10. Wood JN, Bevan SJ, Coote P, Darn PM, Harmar A, Hogan P, Latchman DS, Morrison C, Rougon G, Theiveniau M and Wheatley SC: Novel cell lines display properties of nociceptive sensory neurons. Proc Royal Soc Series B 241: 187-194, 1990.
11. Suburo AM, Wheatley SC, Horn DA, Gibson SJ, Jahn R, Fischer-Colbrie R, Wood JN, Latchman DS and Polan JM: Intracellular redistribution of neuronpeptides and secretory proteins during differentiation of neuronal cell lines. Neuroscience 46: 881-889, 1992.
12. Lillycrop KA, Budhram-Mahadeo VS, Lakin ND, Terrenghi G, Wood JN, Polak JM and Latchman DS: A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 20: 5093-5096, 1992.
13. Lakin ND, Palmer R, Lillycrop KA, Howard MK, Burke LC, Thomas NSB and Latchman DS: Down regulation of the octamer binding protein Oct-1 during growth arrest and differentiation of a neuronal cell line. Mol Brain Res 28: 47-54, 1995.
14. Lillycrop KA, Dent CL, Wheatley SC, Beech MN, Ninkina NN, Wood JN and Latchman DS: The octamer binding protein Oct-2 represses HSV immediate early genes in cell lines derived from latently infectable sensory neurons. Neuron 7: 381-390, 1991.
15. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LS and Rosenfeld MG: Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340: 35-42, 1989.
16. Gerrero MR, McEvilly RJ, Tuner E, Lin CR, O'Connell S, Jenne KJ, Hobbs MV and Rosenfeld MG: Brn 3.0: A POU domain protein expressed in the sensory immune and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci USA 90: 10841-10845, 1993.
17. Theil T, McLean-Hunter S, Zornig M and Möröy T: Mouse Brn-3 family of POU transcription factors: a new amino terminal domain is crucial for the oncogenic activity of Brn-3A. Nucleic Acids Res 21: 5921-5929, 1993.
18. Turner EE, Jenne KJ and Rosenfeld MG: Brn-3.2: A Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid. Neuron 12: 205-218, 1994.
19. Budhram-Mahadeo VS, Theil T, Morris PJ, Lillycrop KA, Möröy T and Latchman DS: The DNA target site for the Brn-3 POU family transcription factors can confer responsiveness to cyclic AMP and removal of serum in neuronal cells. Nucleic Acids Res 22: 3092-3098, 1994.
20. Smith MD and Latchman DS: The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells. Int J Cancer 67: 653-660, 1996.
21. Budhram-Mahadeo VS, Morris PJ, Lakin ND, Theil T, Ching GY, Lillycrop KA, Möröy T, Liem RKH and Latchman DS: Activation of the α-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J Biol Chem 270: 2853-2858, 1995.
22. Lakin ND, Morris PJ, Theil T, Sato TN, Moroy T, Wilson MC and Latchman DS: Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor. J Biol Chem 270: 15858-15863, 1995.
23. Morris PJ, Theil T, Ring CJA, Lillycrop KA, Möröy T and Latchman DS: The opposite and antagonistic effects of the closely related POU family, transcription factors on the activity of a target promoter are dependent upon differences in the POU domain. Mol Cell Biol 14: 6907-6914, 1994.
24. Morris PJ, Lakin ND, Dawson SJ, Ryabanin AE, Kilimann MW, Wilson MC and Latchman DS: Differential regulation of genes encoding synaptic proteins by members of the Brn-3 sub family of POU transcription factors. Mol Brain Res (In press).
25. Budhram-Mahadeo V, Morris PJ, Lakin ND, Dawson SJ and Latchman DS: The different activities of the two activation domains of the Bm-3a transcription factor are dependent on the context of the binding site. J Biol Chem 271: 9108-9113, 1996.
26. Dawson SJ, Morris PJ and Latchman DS: A single amino acid change converts an inhibiting transcription factor into an activator. J Biol Chem 271: 11631-11633, 1996.
27. Klemm JD, Rould MA, Aurora R, Herr W and Pabo CO: Crystal structure of the Oct-1 POU domain bound to an octamer site. DNA recognition with tethered DNA-binding molecules. Cell 77: 21-23, 1994.
28. Lai JS, Cleary MA and Herr W: A single amino acid exhange transfers VP-16 induced positive control from the Oct-1 to the Oct-2 POU, homeodomain. Genes Develop 6: 2058-2065, 1992.
29. Pomerantz JL, Kristie TM and Sharp PA: Recognition of the surface of a homeo domain protein. Genes Develop 6: 2047-2057, 1992.
30. Osen-Sand A, Catsicas M, Staple JK, Jones KA, Ayala G, Knowles J, Grenningloh G and Catsicas S: Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 364: 445-448, 1993.
31. Smith MD, Dawson SJ and Latchman DS: The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Mol Cell Biol 17: 345-354, 1997.
32. Smith MD, Dawson SJ and Latchman DS: Inhibition of neuronal process outgrowth and neuronal specific gene activation by the Brn-3b transcription factor. J Biol Chem 272: 1382-1388, 1997.
33. Liu YZ, Dawson SJ and Latchman DS: Alternative splicing of the Brn-3a and Brn-3b transcription factor mRNAs is regulated in neuronal cells. J Mol Neurosci 7: 77-85, 1996.